
    
      To compare the LBDL group and LDL group in the advanced gastric cancer. A prospective
      randomized controlled trial will be performed in the GI department, Guangdong provincial
      hospital of Chinese Medicine from November 2016 to November 2024. The sample size，100 cases
      with advanced gastric cancer, will be needed after calculated by the statistics. The 100
      cases will be randomly divided into two groups: LBDL group and LDL group. Primary outcomes
      are the 3 years' Disease-free survival (DFS) rate, The secondary outcomes are the 3 years'
      and 5 years' Disease-free survival (DFS) rate, the 3 years and 5 years Overall
      survival（OS）rate, operative time, the total blood loss, the intra-operative complication and
      the post-operative complication, the number of lymph nodes dissected, the number of
      conversion to open laparotomy, and the other outcomes are the average time of ground
      activities, the hospital stay. The data in two groups will be compared.
    
  